Transforming silicon from an inert mineral into a functional nutraceutical ingredient requires advanced processing, stabilization, and formulation expertise.
For brands and manufacturers, the challenge is not sourcing silicon, but converting it into a bioavailable, stable, and formulation-ready form capable of delivering consistent performance.
At Silicium Laboratories, this transformation is achieved through controlled processes that convert silica into highly bioavailable forms such as monomethylsilanetriol (MMST).
Silicon is the second most abundant element in the Earth’s crust. It is primarily found as silicon dioxide (silica) in mineral forms such as quartz and sand.
In its natural state, silicon is:
From a formulation standpoint, this means that raw silica cannot be effectively utilized in nutraceutical applications without prior transformation.
To make silicon functionally relevant, it must be converted into forms compatible with biological systems.
This transformation involves a controlled, multi-step process:
1. Purification
Silica is isolated and purified from mineral sources to ensure consistency, quality, and compliance with nutraceutical standards.
2. Chemical Transformation
Through processes such as hydrolysis and methylation, silica is converted into monomethylsilanetriol (MMST).
This step is critical, as it:
3. Stabilization and Formulation
Once transformed, MMST must be stabilized to prevent re-polymerization and loss of bioavailability.
This stage ensures:
In silicon-based ingredients, bioavailability is the primary determinant of functional efficacy.
Unstabilized or poorly formulated silicon sources tend to polymerize into larger, insoluble structures, significantly reducing absorption.
In contrast, MMST is designed to:
For formulators, this translates into predictable performance and improved ingredient reliability. (See post “LIVING SILICA’s Innovation: Unlocking Bioavailability for Better Results”).
Bioavailable silicon is associated with several physiological processes.
It plays a role in the structure of:
These functions make silicon relevant for formulations targeting:
The role of silicon in human physiology has been explored in multiple studies, particularly in relation to connective tissue and bone metabolism.
Studies published in journals such as the Journal of Trace Elements in Medicine and Biology suggest that silicon may contribute to:
While research continues to evolve, these findings reinforce the importance of using stabilized, bioavailable forms in nutraceutical formulations.
At Silicium Laboratories, we focus on bridging the gap between raw mineral sources and high-performance nutraceutical ingredients.
Our LIVING SILICA® portfolio is developed to deliver:
This enables our partners to develop products with enhanced functionality and clear scientific positioning.
The value of silicon in nutraceuticals does not lie in its abundance, but in its transformation.
By converting inert silica into bioavailable forms such as MMST (and ensuring their stability within formulations) silicon becomes a reliable, functional, and differentiating ingredient for modern product development.
For technical documentation, formulation support, or ingredient specifications:
Or fill out the form: